News

Subscribe Newsboard
Set period
Jul 03, 2023
Laborjournal on Seamless Therapeutics

In their news article in Laborjournal, the Dresden-based start-up Seamless Therapeutics reflects on programmable recombinases.
May 31, 2023
Jenna Hoersten represented the Buchholz Lab at the 26th ASGCT Annual Meeting in Los Angeles

Our PhD student Jenna participated at this year’s ASGCT Annual Meeting in Los Angeles.
May 31, 2023
New publication on tyrosine-type site-specific recombinases

Our new paper “Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering” in collaboration with DKMS Life Science Lab has been published at Nucleic Acids Research.
Apr 26, 2023
Frank Buchholz participating in open discussion on genetic research

During audience discussions, experts exchange views on current questions of genetic research in a relaxed atmosphere. Frank Buchholz will be one of the experts.
Seamless Therapeutics © Seamless Therapeutics
Mar 16, 2023
The TU Dresden Spin-off Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Design-er Recombinases in Dresden
You ask we explain Podcast © © Kristof Presslein
Mar 16, 2023
Frank Buchholz featured in DHMD podcast “You Ask We Explain”
Felix Lansing honoured with the Dresden Excellence Award © Photographer: Jürgen Männel (juergen_maennel@web.de)
Mar 13, 2023
Dresden Excellence Award for Dr. Felix Lansing
Feb 22, 2023
Shady Sayed wins Young Investigator Award

Our postdoc Shady Sayed is one of the winners of the Young Investigator Award of the 21st International AEK Cancer Congress.
Jan 19, 2023
Shady Sayed representing the Buchholz Lab at the 21st International AEK Cancer Congress in Kassel

Shady Sayed’s abstract has been selected as an abstract short talk at the 21st International AEK Cancer Congress in Kassel from February 15 to 17, 2023.